Journal of Oncology

Table of Contents: 2012

  • Journal of Oncology -
  • Special Issue
  • - Volume 2012
  • - Article ID 872713
  • - Review Article

Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma

Gabriele Parenti | Benedetta Zampetti | ... | Massimo Mannelli
  • Journal of Oncology -
  • Special Issue
  • - Volume 2012
  • - Article ID 814014
  • - Review Article

Stem Cells as a Tool for Breast Imaging

Maria Elena Padín-Iruegas | Rafael López López
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 901783
  • - Research Article

Chronic Myelogenous Leukemia Cells Contribute to the Stromal Myofibroblasts in Leukemic NOD/SCID Mouse In Vivo

Ryosuke Shirasaki | Haruko Tashiro | ... | Naoki Shirafuji
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 645146
  • - Research Article

Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?

Gianluigi Taverna | Luigi Benecchi | ... | Pierpaolo Graziotti
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 732874
  • - Review Article

MicroRNAs in Human Malignant Gliomas

Masahiro Mizoguchi | Yanlei Guan | ... | Tomio Sasaki
  • Journal of Oncology -
  • Special Issue
  • - Volume 2012
  • - Article ID 438647
  • - Review Article

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET

B. B. Koolen | W. V. Vogel | ... | R. A. Valdés Olmos
  • Journal of Oncology -
  • Special Issue
  • - Volume 2012
  • - Article ID 213421
  • - Review Article

Breast Imaging: How We Manage Diagnostic Technology at a Multidisciplinary Breast Center

Alejandro Tejerina Bernal | Antonio Tejerina Bernal | ... | Armando Tejerina Gómez
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 584219
  • - Review Article

Malignant Melanoma and Its Stromal Nonimmune Microecosystem

Gérald E. Piérard | Claudine Piérard-Franchimont | Philippe Delvenne
  • Journal of Oncology -
  • Special Issue
  • - Volume 2012
  • - Article ID 647684
  • - Clinical Study

Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors

Faruk Tas
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 521215
  • - Review Article

Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck

Walid Shaib | Scott Kono | Nabil Saba
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 575647
  • - Research Article

Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation

Melissa M. Alegre | Richard A. Robison | Kim L. O'Neill
  • Journal of Oncology -
  • Special Issue
  • - Volume 2012
  • - Article ID 647206
  • - Review Article

Potential Role of Garcinol as an Anticancer Agent

Nadia Saadat | Smiti V. Gupta
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 491685
  • - Research Article

Acquiring Metastatic Competence by Oral Squamous Cell Carcinoma Cells Is Associated with Differential Expression of -Tubulin Isoforms

Becky Lou | David Engler | ... | Nadarajah Vigneswaran
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 928127
  • - Review Article

Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis

Ramandeep Rattan | Rouba Ali Fehmi | Adnan Munkarah
  • Journal of Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 597467
  • - Review Article

Technical Advances and Pitfalls in Head and Neck Radiotherapy

Upendra Parvathaneni | George E. Laramore | Jay J. Liao
Journal of Oncology
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision136 days
Acceptance to publication68 days
CiteScore3.900
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.